Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

NCT01146834 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: bortezomib (Velcade)
DRUG: cyclophosphamide
DRUG: G-CSF
DRUG: Plerixafor

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]